International Clinical Trial: A study in healthy men of the absorption of radiolabelled [14C]LTG-001, how the body breaks it down, and how quickly the body gets rid of it

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN16655785) titled 'A study in healthy men of the absorption of radiolabelled [14C]LTG-001, how the body breaks it down, and how quickly the body gets rid of it' on Sept. 29.

Study Type: Interventional

Study Design: Open-label single-dose study (Other, Safety)

Primary Sponsor: Latigo Biotherapeutics, Inc.

Condition: This trial is in healthy volunteers Other

Intervention: This is a single-period, single-dose, non-randomised, open-label study. We'll give healthy male volunteers a single dose of test medicine to find out how the body breaks down and gets rid of the test medicine. The test medicine will be 'radiolabelled' - it wil...